1. Home
  2. TECK vs NTRA Comparison

TECK vs NTRA Comparison

Compare TECK & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teck Resources Ltd

TECK

Teck Resources Ltd

HOLD

Current Price

$51.15

Market Cap

25.5B

Sector

N/A

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$242.92

Market Cap

27.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECK
NTRA
Founded
1913
2003
Country
Canada
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.5B
27.0B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
TECK
NTRA
Price
$51.15
$242.92
Analyst Decision
Buy
Strong Buy
Analyst Count
7
15
Target Price
$55.14
$249.53
AVG Volume (30 Days)
3.8M
1.1M
Earning Date
02-18-2026
02-26-2026
Dividend Yield
0.68%
N/A
EPS Growth
166.96
N/A
EPS
1.80
N/A
Revenue
$7,526,796,802.00
$2,116,676,000.00
Revenue This Year
$18.19
$33.42
Revenue Next Year
$8.14
$16.96
P/E Ratio
$29.41
N/A
Revenue Growth
29.08
38.17
52 Week Low
$28.32
$125.38
52 Week High
$54.00
$256.36

Technical Indicators

Market Signals
Indicator
TECK
NTRA
Relative Strength Index (RSI) 58.97 57.71
Support Level $49.70 $226.66
Resistance Level $54.00 $243.03
Average True Range (ATR) 1.47 10.13
MACD 0.00 -0.29
Stochastic Oscillator 55.78 56.80

Price Performance

Historical Comparison
TECK
NTRA

About TECK Teck Resources Ltd

Teck is a base metals miner with copper and zinc operations in Canada, the United States, Chile, and Peru. After selling its metallurgical coal business, copper is now its major commodity by EBITDA contribution, followed by zinc. Teck is a top-three zinc miner. Its major new copper mine in Chile at the majority-owned Quebrada Blanca 2, in partnership with Sumitomo, will drive an increase in Teck's attributable copper production by roughly 75%. Along with a number of additional copper growth options, Teck's strategy is to rebalance its portfolio to low-carbon metals such as copper. It sold its oil sands business in early 2023 and its coal business in mid-2024. In September 2025, it agreed to merge with Anglo American.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: